Dr. Michael Eaton, MD

Claim this profile

Franciscan Health Indianapolis

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
14 drugs studied

Area of expertise

1Lung Cancer
Michael Eaton, MD has run 4 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
EGFR negative
2Non-Small Cell Lung Cancer
Michael Eaton, MD has run 3 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
EGFR negative

Affiliated Hospitals

Image of trial facility.
Franciscan Health Indianapolis
Image of trial facility.
Franciscan Health Mooresville

Clinical Trials Michael Eaton, MD is currently running

Image of trial facility.

TTFields + Pembrolizumab

for Lung Cancer

This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T System with IV pembrolizumab in subjects previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The primary objective is to evaluate the progression-free survival (PFS) by RECIST 1.1 in subjects with TPS ≥1 percent, 1L metastatic/current advanced NSCLC treated with TTFields concomitant with pembrolizumab compared to those treated with pembrolizumab alone. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields) to the region of the malignant tumor, by means of surface, insulated electrode arrays.
Recruiting1 award Phase 28 criteria

More about Michael Eaton, MD

Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Eaton, MD has experience with
  • NovoTTF-200T
  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • NovoTTF-100L
  • Docetaxel
  • Gemcitabine
Breakdown of trials Michael Eaton, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Small Cell Carcinoma
Oropharyngeal Carcinoma

Other Doctors you might be interested in

Subhash C. SharmaFranciscan Health Indianapolis
Sameer Z. AhmedFranciscan Health Indianapolis
Nibal SaadMemorial Hospital of South Bend

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Eaton, MD specialize in?
Michael Eaton, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Michael Eaton, MD currently recruiting for clinical trials?
Yes, Michael Eaton, MD is currently recruiting for 1 clinical trial in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Michael Eaton, MD has studied deeply?
Yes, Michael Eaton, MD has studied treatments such as NovoTTF-200T, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Michael Eaton, MD?
Apply for one of the trials that Michael Eaton, MD is conducting.
What is the office address of Michael Eaton, MD?
The office of Michael Eaton, MD is located at: Franciscan Health Indianapolis, Indianapolis, Indiana 46237 United States. This is the address for their practice at the Franciscan Health Indianapolis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top